Hamrick Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
8,334
-1,492
-15% -$511K 2% 11
2026
Q1
$3.46M Buy
9,826
+1,426
+17% +$508K 1.92% 15
2025
Q4
$2.75M Buy
+8,400
New +$2.66M 2.04% 14

Other funds holding AMGN

Hamrick Investment Counsel's AMGN Position: Q2 2026 in Review

Hamrick Investment Counsel reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $511K and leaving 8,334 shares worth $3.02M. The position accounts for 2% of the portfolio, ranked #11.

Hamrick Investment Counsel first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.46M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hamrick Investment Counsel held 8,334 shares of Amgen worth $3.02M as of Q2 2026.
  • Hamrick Investment Counsel sold 1,492 Amgen shares in Q2 2026, an estimated $511K.
  • Amgen made up 2% of Hamrick Investment Counsel's portfolio in Q2 2026, its #11 holding.
  • Hamrick Investment Counsel first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Hamrick Investment Counsel's Amgen position peaked at $3.46M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.